Exact Sciences
EXAS
#1767
Rank
S$12.65 B
Marketcap
$68.39
Share price
-3.29%
Change (1 day)
-15.91%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of September 2024 : S$3.66 Billion

According to Exact Sciences's latest financial reports the company's total debt is S$3.66 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$3.37 B2.86%
2022-12-31S$3.28 B1.86%
2021-12-31S$3.22 B4.45%
2020-12-31S$3.08 B139.47%
2019-12-31S$1.28 B36.74%
2018-12-31S$0.94 B15717.01%
2017-12-31S$5.95 M-25.12%
2016-12-31S$7.95 M-6.58%
2015-12-31S$8.5 M116.55%
2014-12-31S$3.92 M-28.96%
2013-12-31S$5.53 M121.3%
2012-12-31S$2.49 M93.01%
2011-12-31S$1.29 M0.54%
2010-12-31S$1.28 M-53.85%
2009-12-31S$2.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$0.19 B-94.80%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$26.16 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.39 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
S$33.82 B 823.03%๐Ÿ‡ซ๐Ÿ‡ท France